KRBP - Balance Sheet - Kiromic BioPharma, Inc.

Current Liabilities	20.9 M
Accounts Payable	2.68 M
Short-Term Debt	685 K
Other Current Liabilities	17.5 M
Non-Current Liabilities	13.5 M
Long-Term Debt	13.7 M
Other Non-Current Liabilities	-228 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	1.1	3.2	0.6	25.4	10.2	1.9	0.4
Short Term Investments	0	0	0	0	0	0	0
Receivables	0	0	0	16.2 K	0	0	24.3 K
Inventory	0	0	0	0	0	22.2 K	16.3 K
Other Current Assets	2.2	1.2	1.0	3.4	1.2	89.1 K	0.1
Total Current Assets	3.3	4.4	1.7	27.1	10.7	2.0	0.6
PP&E	5.2	7.7	10.3	3.6	2.1	0.6	0.3
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0
Other Long Term Assets	21 K	21.4 K	24.4 K	31.1 K	24.4 K	24.4 K	17.8 K
Other Assets	0	0	0	0	0	0	0
Total Assets	8.5	12.2	12.0	30.7	12.8	2.7	0.9
LIABILITIES
Accounts Payable	2.7	2.1	7.3	2.2	0.7	0.5	0.2
Short Term Debt	0.7	14.6	5.0	0.5	0.5	0	0
Other Current Liabilities	17.5	3.6	1.0	0.7	0.3	0.2	0.4
Total Current Liabilities	20.9	20.4	13.3	3.4	1.5	0.7	0.6
Long Term Debt	13.7	0.9	4.5	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	(0.2)	0	0	0	0	0	0
Total Liabilities	21.1	21.3	17.7	3.4	1.5	0.7	0.6
EQUITY
Common Stock	2 K	1.26 K	648	9.3 K	1.2 K	0	0
Retained Earnings	(149.8)	(122.9)	(101.9)	(67.2)	(41.6)	(22.4)	(18.7)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	(0.3)
Total Equity	(12.6)	(9.1)	(5.8)	27.3	11.4	2.0	0.3
Total Liabilities and Equity	8.5	12.2	12.0	30.7	12.8	2.7	0.9
SHARES OUTSTANDING
Common Shares Outstanding	26.1	32.9	16.3	11.4	7.3	3.9	3.5

Free